WEKO3
アイテム
{"_buckets": {"deposit": "0d16f777-5925-4647-9187-b602d2804a29"}, "_deposit": {"created_by": 1, "id": "71373", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "71373"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00071373", "sets": ["28"]}, "author_link": ["701780", "701788", "701784", "701778", "701785", "701786", "701789", "701781", "701782", "701783", "701787", "701779"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2013-09-25", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Purpose/Objective (s): Radiation therapy for cancer often has severe side effects that limit its efficacy. Because these side effects are in part determined by p53-mediated apoptosis, temporary suppression of p53 has been suggested as a therapeutic strategy to relieve the damage of normal tissues during treatment of p53-deficient tumors. On the other hand, it is known that dissociation of a zinc ion, which is coordinated to metal ion binding site of p53, could induce p53 denaturation, hence we evaluated some zinc chelators as radioprotective p53 inhibitor. As a result, we found 5-chloro-8-quinolinol (KH-3) as a radioprotector that can protect mice from a sublethal dose of 7.5 Gy total-body irradiation (TBI). In this study, we investigated the effects and mechanism of KH-3 comparatively to a known radioprotective p53 inhibitor, PFTm.\n \nMaterials /Methods: Imprinting control region (ICR) female mice, aged 8-week old, were total-body irradiated with an X-ray generator (Pantak-320S, Shimadzu) operated at 200 kV at a dose rate of 0.66 Gy/min. KH-3 (35 mg/kg) or vehicle was ip injected 30 minutes before 7.5 Gy TBI. In cell analysis, highly radiosensitive cell line MOLT-4, derived from human T-cell leukemia, was used and 10 Gy-irradiated. The suppressive effect of KH-3 and the reference compound PFTm on radiation-induced MOLT-4 apoptosis was evaluated using Annexin V-FITC or MitoTracker Red staining. To examine the specificity of KH-3 for p53-mediated apoptosis, we used MOLT-4 cells and their derivatives, namely, p53-knockdown transformant and p53 revertant which re-expressed p53 using shRNA-resistant FLAG-tagged p53-expressing plasmid. To elucidate the mechanism of action of KH-3 in p53-mediated apoptotic pathway, we mainly investigated the expression of p53 target-genes, p21 and PUMA, using quantitative real-time PCR and immunoblotting analyses.\n \nResults: For the 30-day survival study, half of the animals in the KH-3-treated group survived, whereas all the mice receiving only TBI died within 14 days (P \u003c 0.01). Cell death analysis revealed that KH-3 had a higher inhibitory effect on cell death and lower toxicity than that of PFTm in the MOLT-4 cells. KH-3 was ineffective against the radiation-induced apoptosis of p53-knockdown transformant, but suppressed that of p53 revertant. Results indictated that suppression of radiation-induced apoptosis by KH-3 was specifically mediated through p53 signaling pathways. Furthermore, KH-3 modulated p53 target-gene expression without affecting p53 expression. In particular, p21, which has anti-apoptotic activity, was markedly up-regulated by KH-3.\n \nConclusion: KH-3 is a novel kind of radioprotector that modulates p53 transcription. The radioprotective effect of KH-3 may be associated with its ability to up-regulate p21 expression.", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "American Society for Radiation Oncology (ASTRO) Annual Meeting", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "高橋, 一平"}], "nameIdentifiers": [{"nameIdentifier": "701778", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "森田, 明典"}], "nameIdentifiers": [{"nameIdentifier": "701779", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "青木, 伸"}], "nameIdentifiers": [{"nameIdentifier": "701780", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "王, 冰"}], "nameIdentifiers": [{"nameIdentifier": "701781", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "細井, 義夫"}], "nameIdentifiers": [{"nameIdentifier": "701782", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "兼安, 祐子"}], "nameIdentifiers": [{"nameIdentifier": "701783", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "権丈, 雅浩"}], "nameIdentifiers": [{"nameIdentifier": "701784", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "木村, 智樹"}], "nameIdentifiers": [{"nameIdentifier": "701785", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "村上, 雄二"}], "nameIdentifiers": [{"nameIdentifier": "701786", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "永田, 靖"}], "nameIdentifiers": [{"nameIdentifier": "701787", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "王 冰", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "701788", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "細井 義夫", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "701789", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "The mechanism of a novel radioprotector, 8-quinolinol derivative KH-3", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "The mechanism of a novel radioprotector, 8-quinolinol derivative KH-3"}]}, "item_type_id": "10005", "owner": "1", "path": ["28"], "permalink_uri": "https://repo.qst.go.jp/records/71373", "pubdate": {"attribute_name": "公開日", "attribute_value": "2013-11-18"}, "publish_date": "2013-11-18", "publish_status": "0", "recid": "71373", "relation": {}, "relation_version_is_last": true, "title": ["The mechanism of a novel radioprotector, 8-quinolinol derivative KH-3"], "weko_shared_id": -1}
The mechanism of a novel radioprotector, 8-quinolinol derivative KH-3
https://repo.qst.go.jp/records/71373
https://repo.qst.go.jp/records/7137357272faa-9dfd-4de4-bb08-55b5671cfd4f
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2013-11-18 | |||||
タイトル | ||||||
タイトル | The mechanism of a novel radioprotector, 8-quinolinol derivative KH-3 | |||||
言語 | ||||||
言語 | jpn | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
高橋, 一平
× 高橋, 一平× 森田, 明典× 青木, 伸× 王, 冰× 細井, 義夫× 兼安, 祐子× 権丈, 雅浩× 木村, 智樹× 村上, 雄二× 永田, 靖× 王 冰× 細井 義夫 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Purpose/Objective (s): Radiation therapy for cancer often has severe side effects that limit its efficacy. Because these side effects are in part determined by p53-mediated apoptosis, temporary suppression of p53 has been suggested as a therapeutic strategy to relieve the damage of normal tissues during treatment of p53-deficient tumors. On the other hand, it is known that dissociation of a zinc ion, which is coordinated to metal ion binding site of p53, could induce p53 denaturation, hence we evaluated some zinc chelators as radioprotective p53 inhibitor. As a result, we found 5-chloro-8-quinolinol (KH-3) as a radioprotector that can protect mice from a sublethal dose of 7.5 Gy total-body irradiation (TBI). In this study, we investigated the effects and mechanism of KH-3 comparatively to a known radioprotective p53 inhibitor, PFTm. Materials /Methods: Imprinting control region (ICR) female mice, aged 8-week old, were total-body irradiated with an X-ray generator (Pantak-320S, Shimadzu) operated at 200 kV at a dose rate of 0.66 Gy/min. KH-3 (35 mg/kg) or vehicle was ip injected 30 minutes before 7.5 Gy TBI. In cell analysis, highly radiosensitive cell line MOLT-4, derived from human T-cell leukemia, was used and 10 Gy-irradiated. The suppressive effect of KH-3 and the reference compound PFTm on radiation-induced MOLT-4 apoptosis was evaluated using Annexin V-FITC or MitoTracker Red staining. To examine the specificity of KH-3 for p53-mediated apoptosis, we used MOLT-4 cells and their derivatives, namely, p53-knockdown transformant and p53 revertant which re-expressed p53 using shRNA-resistant FLAG-tagged p53-expressing plasmid. To elucidate the mechanism of action of KH-3 in p53-mediated apoptotic pathway, we mainly investigated the expression of p53 target-genes, p21 and PUMA, using quantitative real-time PCR and immunoblotting analyses. Results: For the 30-day survival study, half of the animals in the KH-3-treated group survived, whereas all the mice receiving only TBI died within 14 days (P < 0.01). Cell death analysis revealed that KH-3 had a higher inhibitory effect on cell death and lower toxicity than that of PFTm in the MOLT-4 cells. KH-3 was ineffective against the radiation-induced apoptosis of p53-knockdown transformant, but suppressed that of p53 revertant. Results indictated that suppression of radiation-induced apoptosis by KH-3 was specifically mediated through p53 signaling pathways. Furthermore, KH-3 modulated p53 target-gene expression without affecting p53 expression. In particular, p21, which has anti-apoptotic activity, was markedly up-regulated by KH-3. Conclusion: KH-3 is a novel kind of radioprotector that modulates p53 transcription. The radioprotective effect of KH-3 may be associated with its ability to up-regulate p21 expression. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | American Society for Radiation Oncology (ASTRO) Annual Meeting | |||||
発表年月日 | ||||||
日付 | 2013-09-25 | |||||
日付タイプ | Issued |